Department of Rheumatology, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.
Clinical Rehabilitation Hospital, 700661 Iasi, Romania.
Int J Mol Sci. 2022 Dec 22;24(1):171. doi: 10.3390/ijms24010171.
The temporomandibular joint (TMJ) is a specialized synovial joint that is crucial for the movement and function of the jaw. TMJ osteoarthritis (TMJ OA) is the result of disc dislocation, trauma, functional overburden, and developmental anomalies. TMJ OA affects all joint structures, including the articular cartilage, synovium, subchondral bone, capsule, ligaments, periarticular muscles, and sensory nerves that innervate the tissues. The present review aimed to illustrate the main pathomechanisms involving cartilage and bone changes in TMJ OA and some therapeutic options that have shown potential restorative properties regarding these joint structures in vivo. Chondrocyte loss, extracellular matrix (ECM) degradation, and subchondral bone remodeling are important factors in TMJ OA. The subchondral bone actively participates in TMJ OA through an abnormal bone remodeling initially characterized by a loss of bone mass, followed by reparative mechanisms that lead to stiffness and thickening of the condylar osteochondral interface. In recent years, such therapies as intraarticular platelet-rich plasma (PRP), hyaluronic acid (HA), and mesenchymal stem cell-based treatment (MSCs) have shown promising results with respect to the regeneration of joint structures or the protection against further damage in TMJ OA. Nevertheless, PRP and MSCs are more frequently associated with cartilage and/or bone repair than HA. According to recent findings, the latter could enhance the restorative potential of other therapies (PRP, MSCs) when used in combination, rather than repair TMJ structures by itself. TMJ OA is a complex disease in which degenerative changes in the cartilage and bone develop through intricate mechanisms. The regenerative potential of such therapies as PRP, MSCs, and HA regarding the cartilage and subchondral bone (alone or in various combinations) in TMJ OA remains a matter of further research, with studies sometimes obtaining discrepant results.
颞下颌关节(TMJ)是一种特殊的滑膜关节,对于颌骨的运动和功能至关重要。TMJ 骨关节炎(TMJ OA)是由盘脱位、创伤、功能超负荷和发育异常引起的。TMJ OA 影响所有关节结构,包括关节软骨、滑膜、软骨下骨、囊、韧带、关节周围肌肉和支配组织的感觉神经。本综述旨在说明涉及 TMJ OA 软骨和骨变化的主要病理生理机制,以及一些在体内对这些关节结构具有潜在修复特性的治疗选择。软骨细胞丢失、细胞外基质(ECM)降解和软骨下骨重塑是 TMJ OA 的重要因素。软骨下骨通过异常的骨重塑积极参与 TMJ OA,最初表现为骨量减少,随后是修复机制,导致髁突骨软骨界面的僵硬和增厚。近年来,关节内富含血小板的血浆(PRP)、透明质酸(HA)和间充质干细胞治疗(MSCs)等治疗方法在关节结构再生或防止 TMJ OA 进一步损伤方面显示出有希望的结果。然而,PRP 和 MSCs 比 HA 更常与软骨和/或骨修复相关。根据最近的发现,当联合使用时,后者可以增强其他治疗方法(PRP、MSCs)的修复潜力,而不是单独修复 TMJ 结构。TMJ OA 是一种复杂的疾病,软骨和骨的退行性变化通过复杂的机制发展。PRP、MSCs 和 HA 等治疗方法在 TMJ OA 中对软骨和软骨下骨(单独或各种组合)的再生潜力仍然是进一步研究的问题,研究结果有时存在差异。